SOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING Trademark

Trademark Overview

On Friday, January 13, 2012, a trademark application was filed for SOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING with the United States Patent and Trademark Office. The USPTO has given the SOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING trademark a serial number of 85516259. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by Jennerex, Inc.. The SOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, drug discovery and drug delivery agents consisting of compounds for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer
solve selective oncolytic vaccinia engineering

General Information

Serial Number85516259
Word MarkSOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING
Filing DateFriday, January 13, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 5, 2020
Registration Number4400892
Registration DateTuesday, September 10, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2012

Trademark Statements

Disclaimer with Predetermined Text"SELECTIVE ONCOLYTIC VACCINIA ENGINEERING"
Goods and ServicesPharmaceutical products, drug discovery and drug delivery agents consisting of compounds for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateThursday, May 31, 2012
First Use In Commerce DateThursday, May 31, 2012

Trademark Owner History

Party NameSILLAJEN BIOTHERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameJennerex, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameJennerex, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameJennerex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111

Trademark Events

Event DateEvent Description
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 5, 2020CANCELLED SEC. 8 (6-YR)
Monday, September 10, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 17, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 10, 2013REGISTERED-PRINCIPAL REGISTER
Saturday, August 3, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, August 2, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, August 1, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 12, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, June 17, 2013USE AMENDMENT FILED
Friday, July 12, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 17, 2013TEAS STATEMENT OF USE RECEIVED
Monday, June 17, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 22, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 27, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 19, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 19, 2012ASSIGNED TO LIE
Thursday, October 4, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 3, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 2, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 25, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 25, 2012NON-FINAL ACTION E-MAILED
Wednesday, April 25, 2012NON-FINAL ACTION WRITTEN
Friday, April 20, 2012ASSIGNED TO EXAMINER
Thursday, January 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 17, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

engineering vaccinia oncolytic selective solve pharmaceutical treatment cancer prevention diagnosis drug genetically engineered poxvirus used